| Source NDC Code |
|
Target HCPCS Code |
81481-0803-01
ANKTIVA 400 MCG/0.4 ML VIAL
|
⇄
|
C9169
Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/2024 |
| Number Of Items In Ndc Package |
0.4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IS |
| Billing Units |
ML |
|
|
|
81481-0803-01
ANKTIVA 400 MCG/0.4 ML
|
⇄
|
J9028
INJECTION, NOGAPENDEKIN ALFA INBAKICEPT-PMLN, FOR INTRAVESICAL USE, 1 MICROGRAM
|
| Detail Information |
| Relationship Start Date |
01/01/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
0.4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
IL |
| Billing Units |
ML |
|
|
|
81481-0803-01
ANKTIVA 400 MCG/0.4 ML VIAL
|
⇄
|
J9999
Not otherwise classified, antineoplastic drugs
|
| Detail Information |
| Relationship Start Date |
10/01/2024 |
| Relationship End Date |
12/31/2024 |
| Number Of Items In Ndc Package |
0.4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IS |
| Billing Units |
ML |
|
|
|
81481-0803-01
Anktiva
|
⇄
|
J9028
Inj, nogapendekin pmln, 1mcg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|